TIMO-COMOD

This brand name is authorized in France, Germany, Hong Kong SAR China, Netherlands, Poland, Singapore.

Active ingredients

The drug TIMO-COMOD contains one active pharmaceutical ingredient (API):

1
UNII P8Y54F701R - TIMOLOL MALEATE
 

Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma.

 
Read more about Timolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
S01ED01 Timolol S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
DE Bundesinstitut für Arzneimittel und Medizinprodukte 00835242, 00835259, 05460172, 06894814, 06894820, 06894837
FR Base de données publique des médicaments 66488803
HK Department of Health Drug Office 44928
NL Z-Index G-Standaard 14264382, 14264390
NL Z-Index G-Standaard, PRK 65455, 65463
PL Rejestru Produktów Leczniczych 100107427
SG Health Sciences Authority 13744P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.